All Articles on COVID-19 Vaccine
Unvaccinated volunteers needed for COVID-19 booster trialNIAID-sponsored study includes Seattle in test for benefits of mixing different vaccine types.
NIH-Moderna COVID-19 vaccine receives FDA Emergency Use AuthorizationThe investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
The next stage in COVID-19 vaccine researchIn a Viewpoint for JAMA, KPWHRI’s Dr. Mike Jackson plans ahead to meet the challenges of continuing to evaluate new vaccines.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.